Ensartinib Hydrochloride Market: Strong Growth Driven by Expanding Oncology Applications, FDA Approval for ALK-Positive NSCLC, and Rising Demand for Next-Generation Targeted Cancer Therapies
The Ensartinib Hydrochloride Market is experiencing strong growth as oncology applications expand, FDA approval for ALK-positive non-small cell lung cancer (NSCLC) is secured, and demand for next-generation targeted cancer therapies continues to rise. The global market was valued at approximately USD 0.48–0.6 billion in 2023–2024 and is projected to reach between USD 1.09 billion...
0 Comments 0 Shares 40 Views 0 Reviews